Nisa Investment Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $80.4K | Sell |
1,150
-250
| -18% | -$17.5K | ﹤0.01% | 1463 |
|
|
2025
Q1 | $103K | Buy |
1,400
+750
| +115% | +$55.1K | ﹤0.01% | 1397 |
|
|
2024
Q4 | $42.6K | Sell |
650
-1,150
| -64% | -$75.3K | ﹤0.01% | 1728 |
|
|
2024
Q3 | $140K | Hold |
1,800
| – | – | ﹤0.01% | 1362 |
|
|
2024
Q2 | $140K | Buy |
1,800
+1,400
| +350% | +$109K | ﹤0.01% | 1394 |
|
|
2024
Q1 | $27.1K | Sell |
400
-200
| -33% | -$13.6K | ﹤0.01% | 1798 |
|
|
2023
Q4 | $40.4K | Hold |
600
| – | – | ﹤0.01% | 1689 |
|
|
2023
Q3 | $40.6K | Hold |
600
| – | – | ﹤0.01% | 1790 |
|
|
2023
Q2 | $42.9K | Hold |
600
| – | – | ﹤0.01% | 1799 |
|
|
2023
Q1 | $42K | Sell |
600
-38,000
| -98% | -$2.66M | ﹤0.01% | 1768 |
|
|
2022
Q4 | $2.62M | Buy |
38,600
+38,000
| +6,333% | +$2.58M | 0.02% | 655 |
|
|
2022
Q3 | $33K | Sell |
600
-16,862
| -97% | -$927K | ﹤0.01% | 1892 |
|
|
2022
Q2 | $1.15M | Hold |
17,462
| – | – | 0.01% | 782 |
|
|
2022
Q1 | $1.16M | Buy |
+17,462
| New | +$1.16M | 0.01% | 819 |
|
|
2021
Q4 | – | Sell |
-11,873
| Closed | -$713 | – | 2220 |
|
|
2021
Q3 | $713 | Buy |
+11,873
| New | +$713 | ﹤0.01% | 1019 |
|
|
2020
Q3 | – | Sell |
-4,800
| Closed | -$254K | – | 2249 |
|
|
2020
Q2 | $254K | Hold |
4,800
| – | – | ﹤0.01% | 1225 |
|
|
2020
Q1 | $214K | Sell |
4,800
-1,100
| -19% | -$49K | ﹤0.01% | 1176 |
|
|
2019
Q4 | $294K | Sell |
5,900
-2,300
| -28% | -$115K | ﹤0.01% | 1233 |
|
|
2019
Q3 | $365K | Hold |
8,200
| – | – | ﹤0.01% | 1180 |
|
|
2019
Q2 | $338K | Hold |
8,200
| – | – | ﹤0.01% | 1188 |
|
|
2019
Q1 | $332K | Hold |
8,200
| – | – | ﹤0.01% | 1175 |
|
|
2018
Q4 | $311K | Sell |
8,200
-400
| -5% | -$15.2K | ﹤0.01% | 1131 |
|
|
2018
Q3 | $340K | Buy |
+8,600
| New | +$340K | ﹤0.01% | 1203 |
|